Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Current Contents
Where We Are Indexed
Past Issue Archives
Clinical Communication
In Review
Editorial Board
Information for Authors
Author Form

Reprints, Permissions, & Copyright
Site Map
BACK ISSUE articles are $15 each.
International credit cards NOT accepted.

JCOM Paid Subscribers
user name:
Forgot password?

JCOM Abstract

J Clin Outcomes Manage 
2013 Jan;20(1):36-47
Current treatment strategies for the management of chronic hepatitis B
Wong RJ, Ayoub WS

Abstract Objective: To review current treatment strategies for the management of chronic hepatitis B (CHB). Methods: Review of the literature. Results: There are currently 7 drugs approved by the FDA for the treatment of CHB. Inteferon alfa-2a and peginteferon alfa-2a are injectable immunomodulators, while lamivdine, adefovir, telbivudine, entecavir, and tenofovir are direct-acting oral antiviral agents. The goal of treatment in patients with CHB is to reduce the risk of progressive liver dmage that leads to development of complications such as cirrhosis and hepatocellular carcinoma. The timing of treatment initiation and duration of antiviral therapy varies among society guidelines and incorporates analysis of liver fibrosis in conjunction with the alanine aminotransferase level. Conclusion: Hepatitis B is a chronic disease that requires life-long monitoring.

Case-Based Review

Search the Turner White index to find abstracts of articles published in JCOM.

New issues are posted one month following publication of the printed journal.

View past issue archives:    2013    2012    2011    2010    2009    2008    2007
   2006    2005    2004    2003     2002     2001     2000     1999

Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2019, Turner White Communications
Updated 1/20/14 • jdw